Works matching DE "ANLOTINIB"

Results: 147
    1
    2

    Anlotinib combined with benmelstobart as a chemo-free first-line treatment in advanced esophageal squamous cell carcinoma: an exploratory multicenter, single-arm phase II clinical trial.

    Published in:
    Molecular Cancer, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12943-025-02376-w
    By:
    • Meng, Xiangrui;
    • Yang, Xiuli;
    • Hong, Yonggui;
    • Wang, Wenkang;
    • Zhang, Zhiye;
    • Xia, Jin;
    • Chen, Yunfang;
    • Zhou, Yue;
    • Lu, Taiying;
    • Song, Min;
    • Shan, Zhengzheng;
    • Wu, Tao;
    • Wu, Weilong;
    • Shen, Ling;
    • Guan, Lulu;
    • Ma, Mingying;
    • Wang, Lisen;
    • Luo, Xi;
    • Xin, Dao;
    • Ma, Yihui
    Publication type:
    Article
    3
    4
    5
    6

    Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.

    Published in:
    Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 652, doi. 10.3390/ph18050652
    By:
    • Hetta, Helal F.;
    • Alqifari, Saleh F.;
    • Alshehri, Khaled;
    • Alhowiti, Amirah;
    • Alharbi, Saud S.;
    • Mirghani, Hyder;
    • Alrasheed, Tariq;
    • Mostafa, Mohamed E. A.;
    • Sheikh, Mohammed;
    • Elodemi, Mahmoud;
    • Alhumaid, Sultan A.;
    • Ramadan, Yasmin N.;
    • Abd Ellah, Noura H.;
    • Sayad, Reem
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001).

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-024-01656-0
    By:
    • Chen, Hua-Jun;
    • Tu, Hai-Yan;
    • Hu, Yanping;
    • Fan, Yun;
    • Wu, Guowu;
    • Cang, Shundong;
    • Yang, Yi;
    • Yang, Nong;
    • Ma, Rui;
    • Jin, Gaowa;
    • Xu, Ximing;
    • Liu, Anwen;
    • Tang, Shubin;
    • Cheng, Ying;
    • Yu, Yan;
    • Xu, Chong-Rui;
    • Zhou, Qing;
    • Wu, Yi-Long
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13885-8
    By:
    • Liu, Xiaoli;
    • Yin, Xiaoyan;
    • Zhuang, Lulu;
    • Wen, Junxu;
    • Wei, Zhonghui;
    • Cui, Wenxing;
    • Yu, Minghao;
    • Zhao, Kaikai;
    • Liu, Lanping;
    • Kong, Lingling;
    • Jiang, Liyang;
    • Jing, Xuquan;
    • Zhu, Hui;
    • Wang, Xunqiang;
    • Dong, Xinjun;
    • Yu, Jinming;
    • Meng, Xiangjiao
    Publication type:
    Article
    40
    41
    42
    43
    44

    Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.

    Published in:
    Cancer Biology & Medicine, 2024, v. 21, n. 5, p. 433, doi. 10.20892/j.issn.2095-3941.2023.0373
    By:
    • Shuzhen Lai;
    • Peijing Li;
    • Xiaohui Liu;
    • Guihong Liu;
    • Tieming Xie;
    • Xing Zhang;
    • Xiaoxuan Wang;
    • Jing Huang;
    • Yiqiang Tang;
    • Zhigang Liu;
    • Guoping Shen;
    • Chaoming Li;
    • Fangxiao Lu;
    • Lei Wang;
    • Fagui Jiang;
    • Caixing Sun;
    • Yuanyuan Chen;
    • Ming Chen
    Publication type:
    Article
    45
    46
    47
    48

    Dynamic alterations of ctDNA associate with the therapeutic outcome in the advanced non‐small cell lung cancer patients who received sintilimab plus anlotinib regime as 1st line therapy.

    Published in:
    Clinical & Translational Medicine, 2023, v. 13, n. 6, p. 1, doi. 10.1002/ctm2.1277
    By:
    • Chu, Tianqing;
    • Yuan, Jie;
    • Lu, Jun;
    • Nie, Wei;
    • Zhong, Runbo;
    • Zhang, Bo;
    • Zhang, Wei;
    • Shi, Chunlei;
    • Qian, Jialin;
    • Zhang, Yanwei;
    • Zhang, Xueyan;
    • Teng, Jiajun;
    • Gao, Zhiqiang;
    • Lou, Yuqing;
    • Li, Jiaqi;
    • Qiang, Huiping;
    • Zhang, Chao;
    • Li, Jin;
    • Xia, Xuefeng;
    • Zhong, Hua
    Publication type:
    Article
    49
    50